Lilly's (LLY) Solanezumab Phase 3 Miss is Credit-Negative Event - Moody's
Go back to Lilly's (LLY) Solanezumab Phase 3 Miss is Credit-Negative Event - Moody's| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1164.67 +4.67 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.00 | 52 Week High | $88.16 | |||
| Open | $1164.15 | 52 Week Low | $67.88 | |||
| Day High | $1187.83 | P/E | 269.60 | |||
| Day Low | $1158.00 | EPS | $4.32 | |||
| Volume | 1,455,594 | |||||
